A Groundbreaking Platform: AI Meets Optogenetics KAIST researchers have unveiled a pioneering preclinical platform that fuses artificial intelligence (AI) with optogenetics to advance both the diagnosis and treatment of Parkinson’s disease. The announcement, made by KAIST president Kwang Hyung Lee on September 22, highlights a collaboration spanning the university’s Biological Sciences, Brain and Cognitive Sciences,…